Shorter sampling interval in pilot - Good idea? [Design Issues]

posted by nobody – 2018-02-27 20:02 (1858 d 08:53 ago) – Posting: # 18472
Views: 3,281


Have a drug with "normal" half-life of some hours in the mean, but considerable variability (BOTH target params). So pilot will be huuuugh and fully replicate (planned: EU submission).

Sponsor wants to make a little cheaper by having only 24 h sampling in the pilot, but considerably longer in the pivotal trial.

Good idea? Regarding sample size estimation for the pivotal (including adjusted acceptance range for Cmax, but standard acceptance range for AUC...).

Any thoughts or numbers? :-)


Kindest regards, nobody

Complete thread:

UA Flag
 Admin contact
22,559 posts in 4,725 threads, 1,607 registered users;
12 visitors (0 registered, 12 guests [including 6 identified bots]).
Forum time: 05:55 CEST (Europe/Vienna)

The penalty for scientific irrelevance is, of course,
that the statistician’s work is ignored by the scientific community.    George E.P. Box

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz